The Patent Finder

Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same

Zogenix, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 15/667,112, filed Aug 2, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,603,290Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
In force
 · Medium confidence
Zogenix International LimitedIn force
Medium confidence
US 11,040,018Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
In force
 · Medium confidence
Zogenix International LimitedIn force
Medium confidence
US 11,406,606Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
In force
 · Medium confidence
Zogenix International LimitedIn force
Medium confidence
US 11,759,440Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
In force
 · Medium confidence
Zogenix International LimitedIn force
Medium confidence
US 11,786,487Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
In force
 · Medium confidence
Zogenix International LimitedIn force
Medium confidence
Application 15/667,112Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
Abandoned
Abandoned Nov 20, 2019
Zogenix International LimitedAbandonedAbandoned Nov 20, 2019
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Zogenix, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited